HOSPITAL UNIVERSITARIO RUBER
Departamento
Hospital General Universitario Gregorio Marañón
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital General Universitario Gregorio Marañón (31)
2024
-
Adjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes
Journal of Clinical Oncology, Vol. 42, Núm. 9, pp. 987-993
2023
-
Correction to: Improving clinical paediatric research and learning from COVID-19: recommendations by the Conect4Children expert advice group (Pediatric Research, (2022), 91, 5, (1069-1077), 10.1038/s41390-021-01587-3)
Pediatric Research
-
Guided Genioplasty: Comparison between Conventional Technique and Customized Guided Surgery
Journal of Personalized Medicine, Vol. 13, Núm. 12
2022
-
Improving clinical paediatric research and learning from COVID-19: recommendations by the Conect4Children expert advice group
Pediatric Research, Vol. 91, Núm. 5, pp. 1069-1077
2021
-
Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study
Annals of Oncology, Vol. 32, Núm. 12, pp. 1571-1581
-
Coexistence of transmural and lateral wavefront progression of myocardial infarction in the human heart
Revista Espanola de Cardiologia, Vol. 74, Núm. 10, pp. 870-877
-
Efficacy and safety of intramuscular administration of allogeneic adipose tissue derived and expanded mesenchymal stromal cells in diabetic patients with critical limb ischemia with no possibility of revascularization: study protocol for a randomized controlled double-blind phase II clinical trial (The NOMA Trial)
Trials, Vol. 22, Núm. 1
-
Expected medium- And long-term impact of the COVID-19 outbreak in oncology
JCO Global Oncology, Vol. 7, pp. 162-172
-
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group
npj Breast Cancer, Vol. 7, Núm. 1
2020
-
Abemaciclib combined with endocrine therapy for the adjuvant treatment of HR1, HER22, node-positive, high-risk, early breast cancer (monarchE)
Journal of Clinical Oncology, Vol. 38, Núm. 34, pp. 3987-3998
-
Calcified plaques in the radial artery: OCT insight
REC: Interventional Cardiology
-
Holistic approach of the care of the infant with hypoxic-ischaemic encephalopathy in Spain
Anales de Pediatria, Vol. 92, Núm. 5, pp. 286-296
-
The evolving microbiome from pregnancy to early infancy: A comprehensive review
Nutrients, Vol. 12, Núm. 1
2019
-
Agreement between results of meta-analyses from case reports and clinical studies, regarding efficacy and safety of idursulfase therapy in patients with mucopolysaccharidosis type II (MPS-II). A new tool for evidence-based medicine in rare diseases
Orphanet Journal of Rare Diseases, Vol. 14, Núm. 1
-
Point-of-care ultrasound: Is it time to include it in the paediatric specialist training program?
Anales de Pediatria, Vol. 91, Núm. 3, pp. 206.e1-206.e13
-
Topiramate plus cooling for hypoxic-ischemic encephalopathy: A randomized, controlled, multicenter, double-blinded trial
Neonatology, Vol. 116, Núm. 1, pp. 76-84
2018
-
Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology
Clinical and Translational Oncology, Vol. 20, Núm. 7, pp. 815-826
-
Consensus statement on biomarkers in breast cancer by the Spanish Society of Pathology and the Spanish Society of Medical Oncology
Revista Espanola de Patologia
-
Correction to: Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology (Clinical and Translational Oncology, (2018), 20, 7, (815-826), 10.1007/s12094-017-1800-5)
Clinical and Translational Oncology
-
Oxidative stress in perinatal asphyxia and hypoxic-ischaemic encephalopathy
Anales de Pediatria, Vol. 88, Núm. 4, pp. 228.e1-228.e9